Nothing Special   »   [go: up one dir, main page]

SE9702242D0 - Vaccine compositions V - Google Patents

Vaccine compositions V

Info

Publication number
SE9702242D0
SE9702242D0 SE9702242A SE9702242A SE9702242D0 SE 9702242 D0 SE9702242 D0 SE 9702242D0 SE 9702242 A SE9702242 A SE 9702242A SE 9702242 A SE9702242 A SE 9702242A SE 9702242 D0 SE9702242 D0 SE 9702242D0
Authority
SE
Sweden
Prior art keywords
vaccine compositions
helicobacter pylori
polypeptides
compositions
pylori infection
Prior art date
Application number
SE9702242A
Other languages
English (en)
Inventor
Thomas Berglindh
Bjoern Mellgaard
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9702242A priority Critical patent/SE9702242D0/sv
Publication of SE9702242D0 publication Critical patent/SE9702242D0/sv
Priority to ZA984696A priority patent/ZA984696B/xx
Priority to ARP980102558A priority patent/AR012896A1/es
Priority to HU0003164A priority patent/HUP0003164A3/hu
Priority to TR1999/03060T priority patent/TR199903060T2/xx
Priority to BR9810026-2A priority patent/BR9810026A/pt
Priority to CA002293293A priority patent/CA2293293A1/en
Priority to PCT/SE1998/001093 priority patent/WO1998056816A1/en
Priority to CN98806101A priority patent/CN1259960A/zh
Priority to IDW991542A priority patent/ID23052A/id
Priority to EEP199900566A priority patent/EE9900566A/xx
Priority to KR1019997011714A priority patent/KR20010013699A/ko
Priority to PL98337503A priority patent/PL337503A1/xx
Priority to AU80487/98A priority patent/AU8048798A/en
Priority to EP98928772A priority patent/EP1009764A1/en
Priority to IL13314498A priority patent/IL133144A0/xx
Priority to SK1730-99A priority patent/SK173099A3/sk
Priority to JP50228399A priority patent/JP2002507118A/ja
Priority to NZ501427A priority patent/NZ501427A/xx
Priority to IS5288A priority patent/IS5288A/is
Priority to NO996132A priority patent/NO996132L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE9702242A 1997-06-12 1997-06-12 Vaccine compositions V SE9702242D0 (sv)

Priority Applications (21)

Application Number Priority Date Filing Date Title
SE9702242A SE9702242D0 (sv) 1997-06-12 1997-06-12 Vaccine compositions V
ZA984696A ZA984696B (en) 1997-06-12 1998-06-01 Vaccine compositions V.
ARP980102558A AR012896A1 (es) 1997-06-12 1998-06-01 Polipeptido flge de helicobacter pylori, composicion de vacuna, uso de dicho polipeptido para la fabricacion de composiciones, metodo de diagnostico invitro, y kit de diagnostico para la deteccion de la infeccion por helicobacter pylori
NZ501427A NZ501427A (en) 1997-06-12 1998-06-08 Vaccine compositions comprising the Helicobacter pylori FlgE (flagella) polypeptide and a mucosal adjuvant
CN98806101A CN1259960A (zh) 1997-06-12 1998-06-08 含有幽门螺杆菌FlgE多肽的疫苗组合物
PL98337503A PL337503A1 (en) 1997-06-12 1998-06-08 Vaccines containing f1ge polypeptide from helicobacter pylori
BR9810026-2A BR9810026A (pt) 1997-06-12 1998-06-08 Composição de vacina, uso de um polipeptìdeo flge de helicobacter pylori ou uma sua forma modificada, uso do mesmo, composição de vacina para induzir uma resposta imune protetora para a infecção do helicobacter pylori, processo de diagnose in vitro da infecção do helicobacter pylori, kit de diagnóstico para a detecção de infecção de helicobacter pylori em um mamìfero incluindo o homem, e, processo para extrair em um mamìfero uma resposta imune protetora contra a infecção pelo helicobacter pylori
CA002293293A CA2293293A1 (en) 1997-06-12 1998-06-08 Vaccine compositions comprising the helicobacter pylori flge polypeptide
PCT/SE1998/001093 WO1998056816A1 (en) 1997-06-12 1998-06-08 VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI FlgE POLYPEPTIDE
HU0003164A HUP0003164A3 (en) 1997-06-12 1998-06-08 Vaccine compositions comprising the helicobacter pylori flge polypeptide
IDW991542A ID23052A (id) 1997-06-12 1998-06-08 KOMPOSISI VAKSIN YANG MENGANDUNG POLIPEPTIDA FlgE HELICOBACTER PYLORI
EEP199900566A EE9900566A (xx) 1997-06-12 1998-06-08 Helicobacter pylori FlgE pol�peptiidi sisaldavad vaktsiinikoostised
KR1019997011714A KR20010013699A (ko) 1997-06-12 1998-06-08 헬리코박터 파일로리 ＦｌｇＥ 폴리펩티드 함유 백신 조성물
TR1999/03060T TR199903060T2 (xx) 1997-06-12 1998-06-08 Helicobacter pylori FlgE polipeptid i�eren a�� bile�imleri.
AU80487/98A AU8048798A (en) 1997-06-12 1998-06-08 Vaccine compositions comprising the (helicobacter pylori) flge polypeptide
EP98928772A EP1009764A1 (en) 1997-06-12 1998-06-08 VACCINE COMPOSITIONS COMPRISING THE $i(HELICOBACTER PYLORI) FlgE POLYPEPTIDE
IL13314498A IL133144A0 (en) 1997-06-12 1998-06-08 Vaccine compositions comprising the helicobacter pylori flge polypeptide
SK1730-99A SK173099A3 (en) 1997-06-12 1998-06-08 Vaccine compositions comprising the helicobacter pylori flge polypeptide
JP50228399A JP2002507118A (ja) 1997-06-12 1998-06-08 ヘリコバクターピロリＦｌｇＥポリペプチドからなるワクチン組成物
IS5288A IS5288A (is) 1997-06-12 1999-12-08 Bóluefnablöndur sem innihalda FlgE pólýpeptíð Helicobacter pylori
NO996132A NO996132L (no) 1997-06-12 1999-12-10 Vaksinesammensetninger som omfatter Heliobacter pylori FlgE- polypeptid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702242A SE9702242D0 (sv) 1997-06-12 1997-06-12 Vaccine compositions V

Publications (1)

Publication Number Publication Date
SE9702242D0 true SE9702242D0 (sv) 1997-06-12

Family

ID=20407351

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702242A SE9702242D0 (sv) 1997-06-12 1997-06-12 Vaccine compositions V

Country Status (21)

Country Link
EP (1) EP1009764A1 (sv)
JP (1) JP2002507118A (sv)
KR (1) KR20010013699A (sv)
CN (1) CN1259960A (sv)
AR (1) AR012896A1 (sv)
AU (1) AU8048798A (sv)
BR (1) BR9810026A (sv)
CA (1) CA2293293A1 (sv)
EE (1) EE9900566A (sv)
HU (1) HUP0003164A3 (sv)
ID (1) ID23052A (sv)
IL (1) IL133144A0 (sv)
IS (1) IS5288A (sv)
NO (1) NO996132L (sv)
NZ (1) NZ501427A (sv)
PL (1) PL337503A1 (sv)
SE (1) SE9702242D0 (sv)
SK (1) SK173099A3 (sv)
TR (1) TR199903060T2 (sv)
WO (1) WO1998056816A1 (sv)
ZA (1) ZA984696B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104784687A (zh) * 2015-04-27 2015-07-22 苏州大学附属第一医院 重组绿脓杆菌鞭毛钩蛋白FlgE的用途
CN113425717B (zh) * 2021-04-22 2023-06-16 成都欧林生物科技股份有限公司 一种提高口服幽门螺杆菌疫苗效力的药剂及其应用
CN116535472B (zh) * 2023-05-31 2024-04-30 四川大学华西医院 一种幽门螺杆菌重组蛋白抗原FlgK及其制备方法与应用
CN118105473B (zh) * 2024-04-30 2024-08-16 成都欧林生物科技股份有限公司 一种预防或治疗Hp感染口服免疫原性组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
AR003125A1 (es) * 1995-06-01 1998-07-08 Astra Ab Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la

Also Published As

Publication number Publication date
NO996132L (no) 2000-01-28
BR9810026A (pt) 2000-09-19
JP2002507118A (ja) 2002-03-05
NO996132D0 (no) 1999-12-10
WO1998056816A1 (en) 1998-12-17
EP1009764A1 (en) 2000-06-21
AU8048798A (en) 1998-12-30
PL337503A1 (en) 2000-08-28
CA2293293A1 (en) 1998-12-17
IS5288A (is) 1999-12-08
CN1259960A (zh) 2000-07-12
ID23052A (id) 2000-01-20
HUP0003164A2 (hu) 2000-12-28
ZA984696B (en) 1999-01-04
HUP0003164A3 (en) 2001-10-29
TR199903060T2 (xx) 2000-09-21
EE9900566A (xx) 2000-06-15
SK173099A3 (en) 2000-06-12
AR012896A1 (es) 2000-11-22
KR20010013699A (ko) 2001-02-26
NZ501427A (en) 2000-09-29
IL133144A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
NO975490D0 (no) Heliobacter pylori antigener og vaksinesammensetninger
DE69529219D1 (en) Helicobacter proteine und impstoffe
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
DE3852761D1 (de) Saponin-hilfsmittel.
FI963281A0 (sv) Ureasbaserat vaccin och behandling av helicobakterieinfektion
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
DE59003895D1 (de) Arbeitszange.
YU79393A (sh) Terapeutska kombinacija
BR9106438A (pt) Composicoes terapeuticas sinergisticas e processos
DE69031902D1 (de) Durch Bestrahlung härtbare Organosiloxangelzusammensetzungen
DK0454735T3 (da) Vaccine sammensætning
HUP9801266A2 (hu) Multimer, rekombináns ureázvakcina
ATE350390T1 (de) Synthetische peptide und impfstoffe welche diese beinhalten
NO893196D0 (no) Hybrid-protein-c-sammensetninger og fremgangsmaater for deres fremstilling.
FI945213A (sv) Silikonsläppmedelkompositioner
PT789590E (pt) Imunopotenciacao induzida por quitosano
NO964238L (no) Halofantrin-fri-base for behandling av malaria og blandinger
DK47885D0 (da) Kompositioner til brug som kosmetiske, sundhedsbevarende og kropsbeskyttende midler
SE9702242D0 (sv) Vaccine compositions V
EP1037918A4 (en) METHOD AND COMPOSITIONS FOR INCREASING THE EFFICIENCY OF VACCINALS USING CHEMOKINES
DE69024400D1 (de) Dem menschlichen Calpastatin ähnliches Polypeptid
SE9702240D0 (sv) Vaccine compositions III
NO963892L (no) Anvendelse av dimeticon for lokal antibakteriell terapi og/eller hindring og terapi i forbindelse med Helicobacter pylori (HP) assosierte syndromer og infeksjonssykdommer
DE69227800D1 (de) Siliconzusammensetzungen
SE9702241D0 (sv) Vaccine compositions IV